| Literature DB >> 11978520 |
W B van den Hout1, M van den Brink, A M Stiggelbout, C J H van de Velde, J Kievit.
Abstract
A concise overview is provided of the methodology of cost-effectiveness analyses, followed by a survey of published CEAs of colorectal cancer treatments. To gain credibility, the methodology applied in CEAs must be further improved. Costs are rarely estimated from the societal perspective, and little is known about how colorectal patients value their treatment and health.Entities:
Mesh：
Year: 2002 PMID： 11978520 DOI： 10.1016/s0959-8049(02)00053-9
Source DB: PubMed Journal: Eur J Cancer ISSN： 0959-8049 Impact factor: 9.162